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a b s t r a c t
The proteasome and autophagy are two major intracellular protein degradation pathways and the regu-
lation of each by ethanol metabolism affects cellular integrity. Using acute and chronic ethanol feeding to
mice in vivo, and precision-cut rat liver slices (PCLS) ex vivo, we examined whether ethanol treatment
altered these proteolytic pathways. In acute studies, we gave C57Bl/6 mice either ethanol or phos-
phate-buffered saline (PBS) by gastric intubation and sacrificed them 12 h later. PCLS were exposed to
0 or 50 mM ethanol for 12 and 24 h with or without 4-methylpyrazole (4MP). In chronic studies we
pair-fed control and ethanol liquid diets for 4–6 weeks to transgenic mice, expressing the green fluores-
cent protein (GFP) fused to the autophagic marker, microtubule associated protein-1 light chain 3 (LC3).
Acute ethanol administration elevated autophagosomes (AVs), as judged by a 1.5-fold increase in LC3II
content over PBS-gavaged control mice. Hepatic proteasome activity was unaffected by this treatment.
Compared with controls, ethanol exposure for 12 and 24 h to PCLS inhibited proteasome activity by
1.5- to 3-fold and simultaneously enhanced AVs by 2- to 5-fold. The decrease in proteasome activity
and the rise in AVs both depended on ethanol oxidation as its inhibition by 4-methylpyrazole (4MP)
blocked both proteasome inhibition and AV induction. Hepatocytes from mice chronically consuming
ethanol exhibited a 1.6-fold decline in proteasome activity, and a 4-fold rise in GFP–LC3 puncta compared
with pair-fed control mice. When we exposed hepatocytes from these animals to MG262, a proteasome
inhibitor, LC3II puncta per cell further increased 2- to 5-fold over untreated cells. Conclusion: Our findings
demonstrate that ethanol metabolism generates oxidants, the levels of which differentially influence the
activities of the proteasome and autophagy.
 2011 Elsevier Inc. All rights reserved.
1. Introduction
The ubiquitin–proteasome system (UPS) is one of the major
intracellular proteolytic systems in eukaryotic cells. This proteo-
lytic system, as well as the 20S proteasome itself are both consid-
ered vital pathways for removing misfolded and damaged proteins
[1–3]. Ethanol metabolism generates acetaldehyde and oxidants
(e.g. peroxynitrite, lipid peroxides) that likely inhibit the protea-
some [4–6], as demonstrated in vivo [7] and in recombinant hepa-
toma cells that metabolize ethanol [8]. No such inhibition has been
observed in cells incapable of ethanol oxidation [8], which has
prompted us and others [4] to suggest that metabolic byproducts
of ethanol oxidation directly interact with and inhibit the
proteasome.
Besides the proteasome, macroautophagy (henceforth called
autophagy) is the second major proteolytic pathway and the
primary hydrolytic pathway that degrades all other cytoplasmic
components. Autophagy begins with the formation of a double-
membrane-bound autophagosome (AV), which sequesters portions
of cytoplasm and eventually fuses with lysosomes. The latter con-
tain acid hydrolases that catalyze degradation of the AV contents.
Autophagy degrades native and oxidized proteins, damaged organ-
elles and lipid droplets to maintain cellular homeostasis, particu-
larly during nutrient starvation and stress [9]. Unlike the
proteasome, autophagy is activated by ethanol exposure as a cellu-
lar defensive mechanism against oxidant stress. This activation is
attributed to mTOR inactivation by reactive oxygen species (ROS)
generated by ethanol metabolism, thereby causing increased AV
formation [10]. The UPS, the 20S proteasome and autophagy are
0006-291X/$ - see front matter  2011 Elsevier Inc. All rights reserved.
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generally thought to act independently, as they each have distinct
subcellular locations and substrate specificity. However, recent
findings reveal the existence of reciprocal cross-talk between these
pathways, such that the loss of proteasome activity is associated
with a gain in autophagy and vice versa [11–14]. Here, we sought
to determine whether this occurred in liver tissue and cells after
ethanol administration. The studies described herein used three
distinct ethanol exposure systems in rodent liver to ascertain
whether ethanol exposure indeed suppressed proteasome activity
while it enhanced AV content, the initial phase of autophagy. Here,
we show that both these changes depended upon ethanol oxida-
tion and were indeed reciprocally related. Further, these hydrolytic
pathways exhibited differential sensitivities to ethanol and
showed evidence that they are mechanistically interlinked.
2. Materials and methods
2.1. Reagents
Anti-LC3B was purchased from Cell Signaling Technology Inc.
(Danvers MA). Anti-CYP2E1 and anti-b-actin were from Calbio-
chem (La Jolla, CA) and Sigma Chemical Co. (St. Louis, MO), respec-
tively. Dr. Michael Felder, University of South Carolina provided
rabbit anti-mouse anti-ADH. We purchased protease inhibitor
cocktail (# P2714-1BTL), the proteasome substrate, N-succinyl-
leucyl-leucyl-valyl-tyrosyl-7-amino-4-methyl-coumarin (N-Suc-
LLVY-AMC), 4-methylpyrazole and other specialized reagents from
Sigma.
2.2. Experimental animals
The Institutional Animal Care and Use Committee of the
N-WIHCS approved all animal procedures. We followed the Guide-
lines for the use and Care of Laboratory Animals published by the
National Institutes of Health. For ex vivo experiments, Wistar rats
were purchased from Charles River Laboratories (Wilmington,
MA) and maintained on Purina rat chow prior to preparing preci-
sion-cut liver slices (PCLS). For acute ethanol studies, we obtained
female C57Bl/6 mice (3–9 months of age) from the National Cancer
Institute, Frederick, MD or from the Jackson Laboratories, Bar Har-
bor, ME. Absolute ethanol was diluted to 50% (v/v) into double
strength (2) phosphate-buffered saline (PBS) and administered
to conscious mice by gastric intubation at a single dose of 6 g/kg
body weight using a 3.8 cm stainless steel gavage needle (Popper
& Sons, Inc., New Hyde Park, NY) attached to a 1 ml syringe. We
gave control animals an equivalent volume (per body wt.) of single
strength (1) PBS. For chronic studies, we used transgenic mice
(obtained from the Riken BioResource Center (Ibaraki, Japan) via
Dr. Howard Fox (UNMC) that express green fluorescent protein
(GFP) fused to the NH2-terminus of microtubule-associated protein
light chain 3 (GFP–LC3). GFP–LC3 protein was constitutively ex-
pressed in all tissues and driven by the cytomegalovirus immedi-
ate-early enhancer linked to the chicken beta-actin promoter
(known as CAG). Mice were paired by weight and fed Lieber–DeC-
arli control or ethanol diet for 35–42 days, using the 10-day adjust-
ment period, during which the ethanol concentration in the diet
was gradually increased [15].
2.3. Precision-cut liver slices (PCLS)
PCLS were prepared exactly as described by Klassen et al., 2008
and incubated in Williams Medium E [16] with zero or 50 mM eth-
anol, (with or without additions) at 37 C in a Dynamic Organ Cul-
ture incubator for durations indicated in the figures. Following
incubation, a sample of media was removed from each vial and
analyzed for ethanol and acetaldehyde concentrations [15,17].
Each liver slice was then sonicated in PBS and analyses were
conducted.
2.4. Hepatocyte isolation and microscopy
Mice were anesthetized by IP injection of Nembutal™ (50 mg/
kg body weight) and livers were perfused with collagenase fol-
lowed by Percoll™ fractionation [18] to isolate mouse hepatocytes.
We seeded hepatocytes onto collagen-IV-coated glass cover slips in
Williams E medium. After cell attachment for 1 h, the medium was
replaced with fresh Williams E medium and incubation was con-
tinued overnight. We then fixed and mounted the cells in 4% para-
formaldehyde using a Vectashield mounting medium with DAPI.
All images were acquired with a Zeiss 510 Meta Confocal Laser
Scanning Microscope.
2.5. Proteasome catalytic assay
Chymotrypsin-like activity of the 20S proteasome was mea-
sured by incubating cell and tissue extracts with the fluorogenic
peptide substrate, N-Suc-LLVY-AMC, using the procedure de-
scribed previously [19]. Proteasome specific activity units are nmo-
les AMC per h per mg protein.
2.6. Lactate dehydrogenase assay
Enzyme activity in both the medium and cell lysates was mea-
sured by the rate of oxidation of 130 lM NADH using 670 lM
pyruvate as the substrate in 100 mM potassium phosphate buffer
(pH 7.5) in a 1.5 ml reaction mixture for 2 min. The percent release
of LDH was expressed as the units of LDH activity in the medium
divided by the sum of the LDH activity units in both the cells and
the medium (100) [8].
2.7. Other assays
Reduced glutathione was measured in liver homogenates, using
the enzymatic recycling technique [20]. We used thiobarbituric
acid [21] to measure lipid peroxides, the levels of which are ex-
pressed as malondialdehyde (MDA) equivalents per gram of liver.
2.8. Tissue fractionation
A portion of mouse liver was homogenized in 0.05 M Tris–HCl,
0.25 M sucrose (pH 7.4) and subjected to differential centrifuga-
tion, as previously described [22]. Subcellular fractions were frozen
at 70 C until they were used for assays.
2.9. Quantification of proteins by Western blot
We separated proteins from cell and tissue lysates on 12% poly-
acrylamide gels (SDS–PAGE) and transferred them onto nitrocellu-
lose membranes, which we subsequently incubated with anti-LC3II
(Cell Signaling Technology Inc.), anti-CYP2E1 (Calbiochem, La Jolla,
CA) or anti-ADH. The membranes were then incubated with either
horseradish peroxidase-conjugated- or fluorescent secondary anti-
bodies and developed using enhanced chemiluminescence (ECL)
(Amersham) or by Odyssey™ infrared imaging system (Licor, Inc.,
Lutz, FL). We densitometrically quantified each immunoreactive
protein band using Quantity One software (Bio-Rad, Hercules,
CA) or by the Licor analysis software. Protein load was normalized
by calculating the densitometric ratio of the protein of interest to
that of b-actin.
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2.10. Statistical analyses
Data are mean values ±SEM. We determined statistical signifi-
cance between two groups by Student’s t-test and among multiple
groups by one way analysis of variance using Newman–keuls post
hoc analysis. A probability value (P) 6 0.05 was statistically
significant.
3. Results
3.1. Acute ethanol administration enhanced LC3II content in mouse
liver while proteasome activity was unchanged
Fifteen minutes after a single acute gavage with 50% ethanol
serum ethanol levels were 113 ± 2 mM. Twelve hours after treat-
ment the serum ethanol level declined to 6.7 ± 0.5 mM, indicating
a rapid ethanol clearance rate in these animals. Ethanol-gavaged
mice exhibited no change in hepatic CYP2E1 activity at 12 h or at
any other time (up to 48 h) after treatment (data not shown). Ser-
um ALT activity in ethanol-fed mice was the same as in controls
(Table 1) but livers from ethanol-fed mice exhibited signs of hepa-
tic oxidant stress, judged by a 40% reduction in hepatic glutathione
(GSH) (controls: 52 ± 4; EtOH-fed: 30 ± 5 nmoles GSH/mg protein;
P = 0.033; N = 4 per group) and a 5.6-fold rise in lipid peroxides
(controls: 283 ± 37; EtOH-fed: 1582 ± 193 nmoles MDA equiv/g li-
ver P = 0.002; N = 4 per group) compared with controls. Despite
these latter changes, hepatic proteasome chymotrypsin-like activ-
ity was the same (Fig. 1A). However, ethanol administration caused
a 1.5-fold rise in liver LC3II content over controls (Fig. 1B). This is
consistent with the rise in AVs in mouse liver 16 h after four
equally-divided ethanol gavages spaced 20 min apart, as recently
reported [10]. Thus, AV content in liver rose without a decline in
proteasome activity 12 h after a single ethanol dose, clearly indi-
cating that AV formation is more sensitive than the proteasome
to ethanol-induced oxidant stress.
3.2. Ethanol metabolism by PCLS suppressed proteasome activity and
enhanced LC3II content
Compared with control liver slices, exposure of PCLS to 50 mM
ethanol caused a 2.7- and 1.5-fold decline in 20S proteasome chy-
motrypsin-like activity and a 5- and 2-fold rise in LC3II content
after 12 and 24 h of incubation, respectively (Fig. 2A and B). Inhibi-
tion of ethanol oxidation by 4-methylpyrazole (4MP) blocked the
decrease in proteasome activity and the rise in LC3II content
(Fig. 2A and B). We confirmed the metabolic blockade by higher
residual media ethanol levels of 44 ± 2 and 34 ± 9 mM after 12
and 24 h, respectively compared with media ethanol levels of
32 ± 2 and 21 ± 9 mM without 4MP (P = 0.002 at 12 h and
P = 0.019 at 24 h). Furthermore, PCLS treated with 50 mM ethanol
alone generated 12.5 lM acetaldehyde; no acetaldehyde was de-
tected in media of PCLS exposed to ethanol and 4MP. Ethanol tox-
icity, judged by a 1.6-fold rise in LDH leakage into the media of
ethanol-treated PCLS relative to controls was detected after 24 h
of exposure (Table 1). Inclusion of 4MP with 50 mM ethanol com-
pletely prevented such leakage (16 ± 6%; NS vs. controls). 4MP
alone did not affect LDH leakage (data not shown). Together, these
findings indicate that ethanol metabolism by liver slices caused a
decline in proteasome activity and the degree of this decrease
was associated with a similar magnitude of increase in LC3
content.
3.3. Chronic ethanol administration suppressed proteasome activity
and enhanced autophagosome content in mouse hepatocytes
In a third ethanol feeding model, we subjected transgenic GFP–
LC3 mice to chronic ethanol feeding for 4–6 weeks. Serum ALT
activity was elevated in sera of ethanol-fed mice compared with
pair-fed control mice (Table 1). Compared with controls, ethanol
feeding caused a 1.7-fold decline in proteasome activity in hepato-
cytes obtained from these animals (Fig. 3A). The reduction in en-
zyme activity was associated with 2.5-fold higher levels of both
CYP2E1 and ADH proteins over pair-fed controls (Table 2). Confocal
microscopy revealed a 4-fold higher number of fluorescent AVs in
hepatocytes of ethanol-fed mice than in cells from pair-fed con-
trols (Fig. 3B, left two panels). We tested whether AV numbers
were sensitive to additional proteasome inhibition, by treating
the hepatocytes overnight with 50 nM MG262. This treatment fur-
ther enhanced the numbers of GFP–LC3 puncta by 2.5-fold in cells
from controls and by 1.3-fold in hepatocytes from ethanol-fed mice
(Fig. 3B, right two panels). Western blot analyses of post-nuclear
and isolated mitochondrial/lysosomal (M/L) fractions from whole
liver also showed 5- to 6-fold higher levels of LC3II protein in eth-
anol-fed mice than in pair-fed controls (Fig. 3C and D). The latter
findings indicate a strong association between the loss of protea-
some activity and the rise in AVs, which was augmented when cells
were treated with MG262.
We determined the correlation between the ethanol-elicited
fold-decrease (relative to controls) in proteasome activity to the
fold-increase (relative to controls) in LC3II content or AV number
in the three ethanol exposure models. Data in Fig. 4 demonstrate
a strong correlation coefficient of 0.83 between these two param-
eters. It will be noted that this plot intersects the ordinate at 1.5,
not at 1 indicating that in the absence of proteasome inhibition,
ethanol administration still enhanced AV (LC3II) content, likely
due to enhanced AV formation. Thus, based upon these results
and the recent finding that the 20S proteasome degrades LC3II
[23] our data indicate that the ethanol-induced decline in protea-
some activity stabilizes LC3II, thereby elevating its content.
4. Discussion
Here we observed that three separate ethanol treatment models
in rodent liver caused differing degrees of liver injury, which, in all
cases, enhanced AV content but differentially decreased protea-
some activity, depending on the extent of tissue injury. Acute eth-
anol administration to mice caused overt but apparently mild signs
of oxidant stress, associated with an increase in AV (LC3II) content,
which likely indicated a rise in the rate of autophagic flux (i.e. en-
hanced AV synthesis [24]). AV induction requires an increased rate
of phagophore formation, which engulfs cytoplasmic materials
while it elongates and matures into a complete autophagosome
[25]. Because the rise in LC3II occurred rapidly (within 12 h after
ethanol administration), it is likely that the swift rate of hepatic
ethanol oxidation generated sufficient oxidants to induce the
Table 1
ALT levels and LDH leakage after ethanol treatment.
Model system ALT (units/liter) LDH (% leakage)
Control EtOH Control EtOH
AcuteA 107 ± 4.8a 109 ± 20.6a ND ND
PCLSB ND ND 23 ± 2a 37 ± 3b
ChronicC 46 ± 12a 97 ± 14b ND ND
All data are mean values (±SEM). Letter symbols have same meaning as in Fig. 1.
Note: ND = not determined.
A Data from acute ethanol studies are taken from animals (5–7 per group) sac-
rificed 12 h after treatment.
B LDH activities were from media and slices (4–8 samples) incubated 24 h.
C Data from chronic ethanol studies are frommice (12–15 per group) subjected to
4–6 weeks of pair-feeding.
264 P.G. Thomes et al. / Biochemical and Biophysical Research Communications 417 (2012) 262–267
Fig. 1. Proteasome activity (panel A) is unaffected by acute ethanol gavage, but LC3II content (panel B) is induced. Data are mean values (±SEM) from 6–7 control (PBS) and
ethanol-gavaged animals 12 h prior to death. Bars with different alphabets are significantly different from each other. Bars with same alphabet are not.
Fig. 2. Ethanol-elicited decline in proteasome activity (panel A) and increase in LC3II in PCLS (panel B). Data are mean values (±SEM) 4–8 samples. Letter symbols have the
same meaning as in Fig. 1. Note: 4MP data were similar to that of EtOH + 4MP and are not shown.
Fig. 3. Chronic ethanol feeding inhibits proteasome activity (panel A) and enhances AVs (panel B) in mouse hepatocytes. Data are mean values (±SEM) of three pairs of
animals. Micrographs show AV’s in pair-fed and ethanol-fed mice hepatocytes in the presence and absence of proteasome inhibitor, MG262. Mean values (±SE) from 15
randomly selected images per group are given under each micrograph. Letter symbols have same meaning as in Fig. 1. Representative immunoblot showing LC3II protein in
liver post-nuclear supernatant (panel C) and in mitochondria/lysosome (M/L) fractions (panel D) relative to b-actin and Lamp-1 as loading controls, respectively, in
fractionated liver homogenates from pair-fed and EtOH-fed mice.
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signaling cascade that enhances AV formation as a defensive re-
sponse [10]. At the same time, acute ethanol treatment left protea-
some activity unaffected, probably because higher sustained serum
alcohol levels (i.e.P40 mM) are usually required to achieve inhibi-
tion of the enzyme in vivo [26]. It is likely that, along with the rapid
rate of ethanol metabolism, the level and/or the duration of oxi-
dant stress was/were insufficient to inhibit the proteasome, as in
these acute experiments we observed a restoration of liver GSH
levels to normal 24 h after ethanol gavage (data not shown).
Proteasome inhibition in PCLS after exposure to 50 mM ethanol
was consistent with our previous findings, which showed that,
high (i.e. 50–100 mM) extracellular ethanol concentrations inhibit
20S proteasome chymotrypsin-like activity in cultured cells [8]. In
PCLS, both proteasome inhibition and AV elevation were depen-
dent on ethanol oxidation. In addition, the finding that 4MP
blocked both acetaldehyde production and LC3II enhancement
indicates that acetaldehyde participated in the elevation of AV con-
tent in PCLS. Additionally, in PCLS, inhibition of proteasome activ-
ity by 50 mM ethanol was likely due to sustained production of
reactive metabolites via ADH- and CYP2E1-catalyzed ethanol oxi-
dation. Compared with the acute studies just described, the reduc-
tion in proteasome activity in PCLS was associated with a greater
degree of increase in the content of LC3II. These findings lead us
to suggest that in ethanol-exposed PCLS, part of the increase in
LC3II was caused by its stabilization, as LC3 is not only degraded
in the autolysosome during normal autophagy but is also a target
of the 20S proteasome [23], clearly indicating a direct interaction
between components of the two degradative systems. Our findings
are consistent with recent reports that the two proteolytic path-
ways are mechanistically interlinked [27]. For example, in re-
sponse to increased production of misfolded proteins, the UPS is
overwhelmed and autophagy is induced as a compensatory mech-
anism to remove misfolded proteins [28]. Conversely, autophagy
inhibition in cultured cardiomyocytes by 3-methyladenine causes
enhanced proteasome chymotrypsin-like activity [14] by mecha-
nism(s) that are undefined.
Our findings from ex vivo studies with PCLS were confirmed by
similar results in vivo, as chronic ethanol feeding to mice reduced
proteasome activity and increased autophagosome content. Pro-
teasome inhibition in hepatocytes after chronic ethanol feeding
to GFP–LC3 transgenic mice also coincided with increased CYP2E1
and ADH contents. Both these proteins are proteasome substrates
[29,30] and their rise indicated that the metabolites generated
from chronic ethanol oxidation likely inhibited not only the 20S
proteasome but also the 26S proteasome, which is the larger ver-
sion of the 20S particle and the key degradative component of
the UPS that selectively degrades ubiquitylated protein substrates
[29,30]. Part of the robust increase in autophagosome number after
chronic ethanol feeding reflected the decline in proteasome activ-
ity coupled with faulty trafficking and degradation of AVs by lyso-
somes. Further confirmation that the proteasome partially
regulates LC3 content was that AV numbers increased in response
to overnight treatment of hepatocytes with MG262.
In summary, autophagosomes were elevated in livers of acute
ethanol fed mice, in ethanol-exposed PCLS and in livers and hepa-
tocytes of chronically ethanol-fed mice, three widely used ethanol
exposure models that exhibit different levels of liver injury. We
conclude that the ethanol-elicited rise in AV formation includes
activation of AV formation, disruption in AV degradation by lyso-
somes and now, AV stabilization by ethanol-induced proteasome
inhibition. These findings indeed indicate reciprocal regulation of
the two proteolytic pathways and provide a cogent explanation
for the same observation in other systems [14]. However, this re-
port is unique in that it is one of the first studies to demonstrate
that the oxidation of ethanol, a natural liver substrate, generates
metabolites that alter the catabolism by the proteasome, of LC3,
the most widely-used biomarker of autophagy.
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